Abstract
Posaconazole therapy may lead to increased serum estradiol levels and development of gynecomastia. Early detection by endocrine hormone measurements may help preventing gynecomastia.
Original language | English (US) |
---|---|
Journal | Clinical Case Reports |
DOIs | |
State | Accepted/In press - 2020 |
Keywords
- 11beta-hydroxylase
- adverse drug effect
- estradiol
- gynecomastia
- hypertension
- hypokalemia
- posaconazole
ASJC Scopus subject areas
- Medicine(all)